Resources

New and Emerging Trends in Cancer Treatment: CAR-T

Home | Resources

In this Syndicated Report focusing on CAR-T therapy, and new and emerging trends in Cancer Treatment, we had two main objectives:

  • To understand the knowledge and excitement level for emerging trends in cancer treatment, specifically with chimeric antigen receptor T cell (CAR-T) therapy
  • To understand the drivers of use and future expectations for autologous vs. allogeneic CAR-T

Interview Exploration: n=3 30-minute interviews with Hematologists profiled as “thought leaders” in new cancer treatments to share experience and hypotheses prior to survey
Methodology: 3-Minute MicroSurvey
Crowds: US Hematologists, US Oncologists
Fielding Period: August 13-15, 2019

Download the report now!

Please fill out the form below to access this content

Related Resources

IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more